The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α

Shu Zhu,Wen Pan,Xinyang Song,Yan Liu,Xinrui Shao,Yuanjia Tang,Dong Liang,Dongyi He,Honglin Wang,Wenjun Liu,Yufang Shi,John B Harley,Nan Shen,Youcun Qian

DOI: https://doi.org/10.1038/nm.2815

IF: 82.9

2012-01-01

Nature Medicine

Abstract:Several microRNAs have been identified that affect lymphocyte effector function and contribute to autoimmune inflammatory disease. Here Youcun Qian and his colleagues find that interleukin-17 (IL-17) suppresses miR-23b expression in nonimmune cells present in inflammatory lesions from individuals with rheumatoid arthritis, systemic lupus erythematosus or multiple sclerosis and in the respective mouse models. MiR-23b targets several signaling molecules downstream of IL-17, TNF-α and IL-1β signaling, thereby suppressing proinflammatory cytokine expression and inhibitng autoimmune pathogenesis in vivo .